Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population developing hepatocellular carcinoma during a period of time
go back to main search page
Accession:CMO:0002602 term browser browse the term
Definition:The number of new cases of hepatocellular carcinoma appearing in a study population during a certain period compared to the total number of individuals in the study population, expressed as a percentage.
Synonyms:related_synonym: hepatocellular carcinoma incidence;   malignant hepatocellular carcinoma incidence
 xref: MESH:D006528



show annotations for term's descendants           Sort by:

Related Phenotype Data for Term "percentage of study population developing hepatocellular carcinoma during a period of time" (CMO:0002602)

Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    tumor measurement 88
      liver tumor measurement 0
        liver tumor incidence/prevalence measurement 0
          percentage of study population developing liver tumors during a period of time 0
            percentage of study population developing malignant liver tumors during a period of time 0
              percentage of study population developing hepatocellular carcinoma during a period of time 0
Path 2
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        organ tumorous lesion measurement 108
          organ tumorous lesion incidence/prevalence measurement 18
            tumor incidence/prevalence measurement 16
              liver tumor incidence/prevalence measurement 0
                percentage of study population developing liver tumors during a period of time 0
                  percentage of study population developing malignant liver tumors during a period of time 0
                    percentage of study population developing hepatocellular carcinoma during a period of time 0
paths to the root